Hepatitis C virus treatment response to ledipasvir/sofosbuvir among patients coinfected with HIV and HCV: Real world data in a black population

Mostrar otras versiones (1)

Treatment of hepatitis C virus (HCV) infection for patients with human immunodeficiency virus (HIV) has improved with direct acting antivirals. However, outcomes among Black persons treated with ledipasvir/sofosbuvir (LDV/SOF) may be inferior to non-Blacks. We assessed responses to LDV/SOF in a coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Banga, Jaspreet, Nizami, Sobia, Slim, Jihad, Nagarakanti, Sandhya, Portilla, Mario, Swaminathan, Shobha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440318/
https://www.ncbi.nlm.nih.gov/pubmed/32176039
http://dx.doi.org/10.1097/MD.0000000000019140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440318/
https://www.ncbi.nlm.nih.gov/pubmed/32176039
http://dx.doi.org/10.1097/MD.0000000000019140

Ejemplares similares